Form D · Biotechnology
CONTRAFECT Corp
Yonkers, NY · CIK 0001478069
Offering snapshot reported Jun 25, 2015 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2015 | Initial | $20,000,000 | No comparison | 9 | SEC filing |
| Mar 12, 2014 | Initial | $0 | No comparison | 1 | SEC filing |
| Sep 4, 2013 | Amendment | $11,963,650 | $1,966,000vs Jul 1, 2013 | 124 | SEC filing |
| Jul 1, 2013 | Initial | $9,997,650 | No comparison | 94 | SEC filing |
| Sep 15, 2011 | Initial | $12,502,905 | No comparison | 125 | SEC filing |
| Aug 23, 2010 | Initial | $4,326,603 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.2M
- Finders' fees
- $0
- Form D file number
- 021-242461
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Brookline Group, LLC | 153587 | |
| M.M. Dillon & Co. LLC | 19878 |
Source: Form D, filed Jun 25, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Abeles | Director |
| Sol Barer | Director |
| Sol Barer, Ph.D. | Director |
| Issac Blech | Director |
| Isaac Blech | Director |
| Natalie Bogdanos | Executive |
| Steven C. Gilman, Ph.D. | Director |
| Julia P. Gregory | Director, Executive |
| David Huang, M.D., Ph.D | Executive |
| David N. Low, Jr. | Director |
| Michael Messinger | Executive |
| Robert C. Nowinski | Director, Executive |
| Robert Nowinski, Ph.D. | Director, Executive |
| Michael J. Otto, Ph.D. | Director |
| Roger Pomerantz, Ph.D. | Director |
| David Scheinberg | Director |
| David Scheinberg, M.D., Ph.D. | Director |
| Cary Sucoff | Director |
| Sir Richard Sykes, Frs | Director |
| Lawrence Yuan Tian, Ph.D. | Director |
| Michael Wittekind, Ph.D. | Executive |
| Shengda Zan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
28 Wells Avenue 3 Rd Floor
Yonkers, NY, 10701
Yonkers, NY, 10701